Graphene, power storage device, and electric device
US-9218916-B2 · Dec 22, 2015 · US
US2016355401A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016355401-A1 |
| Application number | US-201515117575-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 2, 2015 |
| Priority date | Mar 4, 2014 |
| Publication date | Dec 8, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are a scroll preparing method using a two-dimensional material and a scroll prepared thereby. The scroll preparing method comprises preparing a two-dimensional material. The two-dimensional material is scrolled by providing an amphiphilic substance having a hydrophilic portion and a hydrophobic portion on the two-dimensional material. As a result, a scroll composite including the amphiphilic substance disposed inside a scroll structure is formed.
Opening claim text (preview).
1 . A scroll composite, comprising: a two-dimensional material scroll with open ends; and an amphiphilic substance disposed inside the scroll. 2 . The composite of claim 1 , wherein the two-dimensional material is a single substance selected from the group consisting of graphene, graphene oxide, boron nitride, boron carbon nitride (BCN), tungsten oxide (WO 3 ), tungsten sulfide (WS 2 ), molybdenum sulfide (MoS 2 ), molybdenum telluride (MoTe 2 ), and manganese oxide (MnO 2 ), or a composite substance including a stack of two or more thereof. 3 . The composite of claim 1 , wherein the amphiphilic substance is a surfactant, a bile acid, a bile acid salt, a hydrate of a bile acid salt, a bile acid ester, a bile acid derivative, or a bacteriophage. 4 . The composite of claim 3 , wherein the surfactant includes one or more compounds selected from the group consisting of sodium dodecyl sulfate (SDS), ammonium lauryl sulfate, sodium laureth sulfate, alkyl benzene sulfonate, cetyl trimethylammonium bromide (CTAB), hexadecyl trimethyl ammonium bromide, an alkyltrimethylammonium salt, cetylpyridinium chloride (CPCl), polyethoxylated tallow amine (POEA), benzalkonium chloride (BAC), benzethonium chloride (BZT), dodecyl betaine, dodecyl dimethylamine oxide, cocamidopropyl betaine, alkyl poly(ethylene oxide), a poloxamer, a poloxamine, alkyl polyglucoside, cetyl alcohol, sodium deoxycholate, cocamide MEA, cocamide DEA, sorbitan ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, polyethyelene glycol hydroxystearate, polyoxyethylene glycolated natural or hydrogenated castor oil, a polyoxyethylene-polyoxypropylene copolymer, a synthetic vitamin E derivative, polyoxyethylene alkyl ester, fatty acid microgol glyceride, polyglyceryl fatty acid ester, and a silicone-based surfactant. 5 . The composite of claim 3 , wherein the bile acid is represented by Formula 1 as follows: where R 1 and R 2 are each independently —H or —OH, R 3 is —(CONH—(CH 2 ) n1 ) n2 —Y 1 , n1 is 1 or 2, n2 is 1 or 0, and Y 1 is —COOH or —SO 3 H. 6 . The composite of claim 5 , wherein the bile acid is at least one selected from the group consisting of cholic acid, chenodeoxycholic acid, deoxycholic acid, lithocholic acid, glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, glycodeoxycholic acid, taurodeoxycholic acid, glycolithocholic acid, and taurolithocholic acid. 7 . The composite of claim 5 , wherein the bile acid salt is sodium glycochenodeoxycholate, sodium taurochenodeoxycholate, sodium taurocholate, sodium dehydrocholate, or sodium deoxycholate. 8 . The composite of claim 5 , wherein the hydrate of the bile acid salt is sodium taurocholate hydrate or sodium cholate hydrate. 9 . The composite of claim 3 , wherein the bile acid derivative is represented by Formula 2 below: where n is 0, 1 or 2, and R 4 to R 7 are each independently a group represented by Formula 3, B 1 m L 1 n G 1 [Formula 3] where B 1 is one group selected from the group consisting of L 1 is a linker of —W 1 —, -Q 1 -, -Q 2 -W 2 —, —W 2 -Q 1 -W 3 —, or —W 4 -Q 2 -W 5 -Q 3 -Q 6 -, W 1 , W 2 , W 3 , W 4 , W 5 , and W 6 are each independently a 1 to a 3 are each an integer of 1 to 4, Q 1 , Q 2 , Q 3 , Q 4 , Q 5 , and Q 6 are each independently G 1 is a group represented by and m is 0 or 1, and n is 0 or 1. 10 . The composite of claim 9 , wherein the bile acid derivative is any one of Formulas 4 to 20: (R)—N-(aminomethyl)-4-((3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamide (R)-methyl-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate (R)-4-((3R,5R,8R,9S,103, 13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-N-(hydroxymethyl)pentanamide (R)—N-(aminomethyl)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamide (R)-4-((3R,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid 5β-cholanic acid-3α,12α-diol 3-acetate methyl ester 5β-cholanic acid-3-one 5β-cholanic acid 3,7-dione methyl ester 5β-cholanic acid-3,7-dione Carbamic(4R)-4-((3R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic anhydride 3R,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-17-((R)-5-((2-methyl-3-oxobutan-2-yl)amino)-5-oxopentan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3-sulfonic acid R)-4-oxo-7-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)octanenitrile 3-((R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)propanoic acid (R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic sulfuric anhydride (R)—N-carbamoyl-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamide 4-((S)-1-((3R,5R,8R,9S,10S,12S,13S,1
Oxidation · CPC title
extending in two dimensions, e.g. plate-like · CPC title
Oxides; Hydroxides · CPC title
obtained by TEM, STEM, STM or AFM · CPC title
one of the carbon atoms being part of an amide group · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.